About Us
Careers
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Your main specialty
Adult & Family Medicine
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology & Oncology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Psychiatry
Pulmonology
Radiation Oncology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Playback speed
0.5x
0.75x
1x (Normal)
1.25x
1.5x
1.75x
2x
10 seconds
S
Adjuvant vs. Neoadjuvant Pembrolizumab in Melanoma: Can Neoadjuvant Immunotherapy Reduce Surgical Morbidity and Improve Survival Benefit?
By
Sapna Patel
4 Videos
187 views
July 1, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
23:16
Melanoma 2023: 33rd Annual Cutaneous Malignancy Update
2023 Updates on Dysplastic Nevi
Feat.
B. Kelley
12:46
Stanford Medicine
FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …
Feat.
A. Betof Warner
09:00
AAD 2024 Insights
AAD 2024 Insights: What's New In Nail Tumors
Feat.
J. Dominguez-Cherit
23:09
Total Health
Key Updates in Skin Melanoma
Feat.
R. Seedor
08:48
David Polsky
Promoting Skin Self-Exam for the Secondary Prevention of Melanoma
17:39
Melanoma Bridge 2023
Major Emerging Paradigm Shifts That Will Change Melanoma Management …
Feat.
A. Eggermont
05:20
Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "Impact of Immune Checkpoint Inhibition on…
Feat.
E. Buchbinder
19:52
OncoAlert
Melanoma Updates: Adjuvant Therapy, Advanced Disease, Uveal Melanoma…
Feat.
A. Betof Warner
21:04
Penn Medicine Abramson Cancer Center
Pediatric Melanoma
Feat.
M. Jen
21:12
Robert Swerlick
Dealing With Melanoma Overdiagnosis: Can We Find an Off-Ramp?
08:46
Sapna Patel
Neoadjuvant Immunotherapy in the Treatment of Melanoma: What Do We K…
52:19
Winship Melanoma and Cutaneous Oncology Symposium
2024 Updates on Neoadjuvant Therapy for Resectable Melanoma
Feat.
S. Patel
13:12
2023 Year in Review
Year in Review: Surgical Treatment of Acral Melanoma
Feat.
M. Leventer
14:00
Melanoma Bridge 2023
Is SLN Biopsy No Longer Necessary for Patients With High-Risk Primar…
Feat.
J. Luke
30:29
NYU Langone
Updates in Treatment with Immunotherapy for Melanoma and Related Mal…
Feat.
J. Weber
20:55
2023 West Oncology Conference
2023 West Oncology Conference: Melanoma Updates
Feat.
M. Mooradian
25:10
Scripps MD Anderson Cancer Center Clinical Hematology & Oncology 2024
Immunotherapy Combinations in Melanoma in 2024
Feat.
J. Moyers
04:45
Sapna Patel
Optimal Duration of Neoadjuvant Treatment in Melanoma: What We Do No…
17:38
Melanoma 2024: 34th Annual Cutaneous Malignancy Update
Beyond the Primary: Comprehensive Evaluation of the Melanoma Patient…
Feat.
F. Fish
11:56
Melanoma Bridge 2023
Adjuvant Therapy in Stage II Melanoma: Tools to Balance the Choice
Feat.
P. Ascierto
